Citizens conferma il rating su Acrivon Therapeutics per i progressi nello studio sul cancro endometriale
Acrivon Therapeutics, Inc. (ACRV) Presents at TD Cowen 46th Annual Health Care Conference - Slideshow (NASDAQ:ACRV) 2026-03-04